IsoFootprint – Paving the Way To Sustainable Isotope Analysis
Now, more than ever, we need to take responsibility for our actions. As global levels of atmospheric carbon dioxide continue to increase, we need to be making positive steps forward to reduce our emissions and remove carbon dioxide from the atmosphere.
Parallel Tracking i-biomarkerT Development with Drug Development for Maximum Benefit
This talk will illustrate, with case studies, how appropriate and timely use of imaging biomarkers can significantly reduce the risk, cost and time of drug development.
The First Discovery of a Single Digit Nanomolar Small Molecule Blocker of a Protein-protein Interaction Target
Nils Hansen, Vipergen ApS, speaking at Discovery Chemistry Congress 2015.
Flow Chemistry Today: Towards Multistep (Enzymatic) Processes
Floris Rutjes, Radboud University Nijmegen, speaking at Flow Chemistry India 2015
Machine Learning and Image Analysis Methods in High-content Screening for Phenotypic Drug and Gene Discovery
Peter Horvath discusses image correction and machine learning methods for phenotypic discovery.
Development of a Point-of-Care Diagnostic for Influenza Detection with Antiviral Treatment Effectiveness Indication
The ability to rapidly determine if a patient has an infectious disease and what type of treatment the infection will respond to, would significantly reduce the treatment decision time, shorten the impact of symptoms, and minimize transfer to others.
Cardiac Point of Care – Current Technology and Future Directions
Paul Collinson, St Georges Healthcare NHS Trust, speaking at Point of Care Diagnostics 2015
Drug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM)
The High Throughput Biomedicine unit at FIMM Technology Centre provides a wide range of biomedical high throughput assays.
Oncology Biomarker Testing Current US Practice Baseline and Emerging Trends
This presentation will outline key issues in oncology biomarker testing and describe findings from a study of practices used by National Cancer Institute (NCI) designated cancer centers, the leading U.S. oncology institutions, for testing key biomarkers in three solid tumors - breast, gastroesophageal and non-small cell lung cancers.
Interfering Peptides Targeting Protein-Protein Interactions
Katja Arndt, University of Potsdam, speaking at Discovery Chemistry Congress 2015.
Novel Chip-based Extraction of miRNA
The chip-system is capable of extracting miRNAs from tumor cell cultures, fresh frozen cells and archive material samples by on-chip gel electrophoresis.